Thermo Fisher Scientific (TMO) Cash from Operations (2009 - 2026)

Thermo Fisher Scientific has disclosed Cash from Operations across 18 years of filings, most recently posting 1192000000.0 for Q1 2026.

• Quarterly Cash from Operations rose 64.87% year-over-year to 1192000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8287000000.0 (up 1.82% YoY) and the FY2025 annual result came in at 7818000000.0, down 9.8% from the prior year.
• Cash from Operations slipped to 1192000000.0 in Q1 2026, from 3457000000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 3723000000.0 in Q4 2023 and troughed at 723000000.0 in Q1 2025.
• A 5-year average of 2072764705.88 and a median of 1960000000.0 in 2024 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2023 — Cash from Operations slumped 66.89% — and 2024, when it soared 71.6%.
• Tracing TMO's Cash from Operations over 5 years: stood at 3487000000.0 in 2022, then gained by 6.77% to 3723000000.0 in 2023, then dropped by 11.63% to 3290000000.0 in 2024, then gained by 5.08% to 3457000000.0 in 2025, then plunged by 65.52% to 1192000000.0 in 2026.
• Business Quant data shows TMO's Cash from Operations at 1192000000.0 in Q1 2026, 3457000000.0 in Q4 2025, and 2239000000.0 in Q3 2025.